Vaxcyte(PCVX) - 2025 Q4 - Earnings Call Transcript

Vaxcyte (NasdaqGS:PCVX) Q4 2025 Earnings call February 24, 2026 04:30 PM ET Company ParticipantsAndrew Guggenhime - President and CFOAsad Haider - Managing DirectorDina Ramadane - Biotech Equity Research AssociateEvan Wang - VP, Equity ResearchGrant Pickering - CEOJim Wassil - EVP and COOJonathan Miller - Equity Research AssociateMike Miletich - Chief Commercial OfficerConference Call ParticipantsCarter Gould - Managing Director and Senior AnalystJoseph Stringer - Senior AnalystRoger Song - Senior Equity Re ...